-
1
-
-
0037284703
-
Lipoprotein(a): An emerging cardiovascular risk factor
-
Lippi G, Guidi G (2003) Lipoprotein(a): An emerging cardiovascular risk factor. Crit Rev Clin Lab Sci 40:1-42
-
(2003)
Crit Rev Clin Lab Sci
, vol.40
, pp. 1-42
-
-
Lippi, G.1
Guidi, G.2
-
2
-
-
0033808772
-
Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism
-
Pati U, Pati N (2000) Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism. Mol Genet Metab 71:87-92
-
(2000)
Mol Genet Metab
, vol.71
, pp. 87-92
-
-
Pati, U.1
Pati, N.2
-
5
-
-
0032498947
-
Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response
-
Lippi G, Braga V, Adami S, Guidi G (1998) Modification of serum apolipoprotein A-I, apolipoprotein B and lipoprotein(a) levels after bisphosphonates-induced acute phase response. Clin Chim Acta 271:79-87
-
(1998)
Clin Chim Acta
, vol.271
, pp. 79-87
-
-
Lippi, G.1
Braga, V.2
Adami, S.3
Guidi, G.4
-
6
-
-
31044448693
-
Lipoprotein[a] and the lipid profile in patients with systemic sclerosis
-
Lippi G, Caramaschi P, Montagnana M, Salvagno GL, Volpe A, Guidi G (2006) Lipoprotein[a] and the lipid profile in patients with systemic sclerosis. Clin Chim Acta 364:345-348
-
(2006)
Clin Chim Acta
, vol.364
, pp. 345-348
-
-
Lippi, G.1
Caramaschi, P.2
Montagnana, M.3
Salvagno, G.L.4
Volpe, A.5
Guidi, G.6
-
7
-
-
0028220870
-
Relationship between lipoprotein(a) levels in serum and some indices of protein synthesis in liver cirrhosis
-
Alessandri C, Basili S, Maurelli M, Andreozzi P, Violi F, Cordova C (1994) Relationship between lipoprotein(a) levels in serum and some indices of protein synthesis in liver cirrhosis. Clin Chim Acta 224:125-129
-
(1994)
Clin Chim Acta
, vol.224
, pp. 125-129
-
-
Alessandri, C.1
Basili, S.2
Maurelli, M.3
Andreozzi, P.4
Violi, F.5
Cordova, C.6
-
8
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative
-
National Kidney Foundation
-
National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39:S1-S246
-
(2002)
Am J Kidney Dis
, vol.39
-
-
-
9
-
-
33244486544
-
Diagnosis and classification of diabetes mellitus
-
American Diabetes Association
-
American Diabetes Association (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(Suppl 1):S43-S48
-
(2006)
Diabetes Care
, vol.29
, Issue.SUPPL. 1
-
-
-
10
-
-
0032966485
-
Biochemical risk factors and patient's outcome: The case of lipoprotein(a)
-
Lippi G, Guidi G (1999) Biochemical risk factors and patient's outcome: The case of lipoprotein(a). Clin Chim Acta 280:59-71
-
(1999)
Clin Chim Acta
, vol.280
, pp. 59-71
-
-
Lippi, G.1
Guidi, G.2
-
11
-
-
0028854118
-
Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus
-
DeMeester CA, Bu X, Gray RJ, Lusis AJ, Rotter JI (1995) Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus. Am J Hum Genet 56:287-293
-
(1995)
Am J Hum Genet
, vol.56
, pp. 287-293
-
-
DeMeester, C.A.1
Bu, X.2
Gray, R.J.3
Lusis, A.J.4
Rotter, J.I.5
-
12
-
-
33645085036
-
Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients
-
Saely CH, Koch L, Schmid F, Marte T, Aczel S, Langer P et al (2006) Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients. Eur J Clin Invest 36:91-97
-
(2006)
Eur J Clin Invest
, vol.36
, pp. 91-97
-
-
Saely, C.H.1
Koch, L.2
Schmid, F.3
Marte, T.4
Aczel, S.5
Langer, P.6
-
13
-
-
0031745253
-
Dominant negative effect of TGF-beta1 and TNF-alpha on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures
-
Ramharack R, Barkalow D, Spahr MA (1998) Dominant negative effect of TGF-beta1 and TNF-alpha on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arterioscler Thromb Vasc Biol 18:984-990
-
(1998)
Arterioscler Thromb Vasc Biol
, vol.18
, pp. 984-990
-
-
Ramharack, R.1
Barkalow, D.2
Spahr, M.A.3
-
14
-
-
0027400471
-
5' Control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family
-
Wade DP, Clarke JG, Lindahl GE, Liu AC, Zysow BR, Meer K et al (1993) 5' Control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA 90:1369-1373
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 1369-1373
-
-
Wade, D.P.1
Clarke, J.G.2
Lindahl, G.E.3
Liu, A.C.4
Zysow, B.R.5
Meer, K.6
-
15
-
-
35549007776
-
Lipoprotein(a), athero-thrombosis and longevity. A historical paradox finally elucidated?
-
Lippi G, Franchini M, Guidi GC (2007) Lipoprotein(a), athero-thrombosis and longevity. A historical paradox finally elucidated? Haematologica 92(3 Suppl):ELT03
-
(2007)
Haematologica
, vol.92
, Issue.3 SUPPL.
-
-
Lippi, G.1
Franchini, M.2
Guidi, G.C.3
-
16
-
-
0032539907
-
Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions
-
Espeland MA, Marcovina SM, Miller V, Wood PD, Wasilauskas C, Sherwin R et al (1998) Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions. Circulation 97:979-986
-
(1998)
Circulation
, vol.97
, pp. 979-986
-
-
Espeland, M.A.1
Marcovina, S.M.2
Miller, V.3
Wood, P.D.4
Wasilauskas, C.5
Sherwin, R.6
|